La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Embecta Résultats passés
Passé contrôle des critères 3/6
Embecta's earnings have been declining at an average annual rate of -47.3%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 0.04% per year.
Informations clés
-47.3%
Taux de croissance des bénéfices
-65.6%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 8.9% |
| Taux de croissance des recettes | 0.04% |
| Rendement des fonds propres | n/a |
| Marge nette | 6.2% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15
Aug 16
Embecta Corp. Just Beat EPS By 79%: Here's What Analysts Think Will Happen Next
Aug 14When Should You Buy Embecta Corp. (NASDAQ:EMBC)?
Jul 13Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 12Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15
Feb 21Embecta Corp.'s (NASDAQ:EMBC) Prospects Need A Boost To Lift Shares
Jul 16Embecta Corp. (NASDAQ:EMBC) Shares Could Be 37% Below Their Intrinsic Value Estimate
Mar 30Embecta Corp. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 17Embecta: Comments On 2nd Earnings Since Spin Off
Sep 04Some Investors May Be Willing To Look Past Embecta's (NASDAQ:EMBC) Soft Earnings
Aug 23Embecta GAAP EPS of $1.07 beats by $0.20, revenue of $291.1M beats by $14.24M
Aug 15Embecta Is A Winner In A Growing Market
Jun 07Embecta: Not Love At First Sight
Apr 04Ventilation des recettes et des dépenses
Comment Embecta gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 1,119 | 70 | 364 | 83 |
| 31 Mar 24 | 1,133 | 70 | 366 | 85 |
| 31 Dec 23 | 1,122 | 55 | 359 | 89 |
| 30 Sep 23 | 1,121 | 70 | 341 | 85 |
| 30 Jun 23 | 1,114 | 47 | 328 | 80 |
| 31 Mar 23 | 1,119 | 94 | 324 | 71 |
| 31 Dec 22 | 1,116 | 160 | 305 | 67 |
| 30 Sep 22 | 1,130 | 224 | 295 | 67 |
| 30 Jun 22 | 1,156 | 338 | 284 | 69 |
| 31 Mar 22 | 1,160 | 380 | 260 | 70 |
| 31 Dec 21 | 1,169 | 408 | 249 | 66 |
| 30 Sep 21 | 1,165 | 415 | 240 | 63 |
| 30 Sep 20 | 1,086 | 428 | 215 | 61 |
| 30 Sep 19 | 1,109 | 432 | 222 | 62 |
Des revenus de qualité: EMBC has a large one-off loss of $28.0M impacting its last 12 months of financial results to 30th June, 2024.
Augmentation de la marge bénéficiaire: EMBC's current net profit margins (6.2%) are higher than last year (4.2%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: EMBC's earnings have declined by 47.3% per year over the past 5 years.
Accélération de la croissance: EMBC's earnings growth over the past year (47.7%) exceeds its 5-year average (-47.3% per year).
Bénéfices par rapport au secteur d'activité: EMBC earnings growth over the past year (47.7%) exceeded the Medical Equipment industry 5.5%.
Rendement des fonds propres
ROE élevé: EMBC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.